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LETTERS TO
THE EDITOR
Clotting profiles and coagulation factors
EDITOR,—Neonates who have clinical signs
of a bleeding diathesis warrant a coagulation
screen to detect an underlying coagulation
disorder. If the specimen collected for a
clotting profile clots then the test cannot
be done and a repeat specimen is required.
Often samples that are clotted are not
repeated due to the commonly held miscon-
ception that for a specimen to clot it must
have normal coagulation factor concentra-
tions.
We aimed to test the hypothesis that if a
coagulation profile specimen clots then the
patient’s clotting profile must be normal. A
retrospective analysis was performed, examin-
ing all neonatal clotting profile specimens that
had clotted, from August 1 1996 to December
26 1998 at the Royal Women’s Hospital, Mel-
bourne, Australia. Clotted specimens were
identified and data were collected from the
clotting profile of specimens repeated later the
same day. The clotting profile included the
prothrombin time (PT) (seconds), activated
partial thromboplastin time (APTT) (sec-
onds), fibrinogen concentration (g/l) and
D-dimer (mg/l). The reference ranges for each
parameter were corrected for postnatal and
gestational age.
Eighteen clotted specimens were taken from
11 neonates. Only nine were repeated on the
same day, two of which clotted again and
blood was not re-collected. Of the remaining
seven specimens, five had abnormal results. Of
those five abnormal results, all had increased
PT, APTT, and D-dimer, and two had an
accompanying low fibrinogen concentration.
In summary, half of the clotted specimens
were not repeated, and 71% of repeated speci-
mens were abnormal.
Only 20–30% of most coagulation factors
are required for clot formation in vivo,1 and
this may also be true for blood collected for
analysis. These data support the principle that
it is wise not to assume that clotted specimens
come from patients with normal clotting pro-
files. We conclude that if a clotting profile is
clinically indicated and the specimen clots,
this does not imply normal coagulation, and
another specimen should be collected for
analysis.
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Clomipramine withdrawal in newborns
EDITOR,—Maternal clomipramine use during
pregnancy may cause epilepsy in newborns.1–3
We present the case of a neonate who
developed a thus far unrecognised manifesta-
tion of clomipramine withdrawal.
A 38 year old woman had been treated for
depression throughout pregnancy with clomi-
pramine (100 mg/day). No other medication
had been taken. A boy weighing 3370 g was
born at term; he had excellent Apgar scores.
Two days later, the child was jittery following
startling impulses. On the fifth day, simultane-
ous and symmetrical jerks of arms and legs
developed, but the child remained alert. The
jerks could be provoked by touch or auditory
stimuli, and stopped by briefly stabilising the
limb. Neither the face nor the eyes showed
abnormal movements. Clomipramine serum
concentration was <10 ng/ml. Other laboratory
tests, cerebrospinal fluid analysis, and ultra-
sound brain scans were unremarkable. Suspect-
ing a status epilepticus, the child was treated
intravenously with clonazepam and phenobar-
bital, without success. Subsequently, a 10-
channel electroencephalogram, recorded while
limb jerks were present, showed no epileptic
activity and a normal background pattern.
We diagnosed a generalised, stimulus sensi-
tive, status myoclonus. A single dose of 0.5 mg
clomipramine suppressed the myoclonus im-
mediately, but caused somnolence. Over the
next four days, the patient had only sporadic
myoclonic jerks, while consciousness im-
proved. Examination three weeks later was
normal, except for mild jitteriness in response
to touch.
This report shows that the clinical spectrum
of clomipramine withdrawal in newborns
includes myoclonus. Limb jerks appeared sev-
eral days after birth and were suppressed by
clomipramine, which suggests a withdrawal
eVect1–4 Myoclonus has hitherto not been rec-
ognised, but epileptic seizures are commonly
reported.1–3 However, EEGs are never per-
formed, except for one neonate with general-
ised clinical manifestations and a focal epilep-
togenic focus.3 Hence, epilepsy was not
unambiguously demonstrated and myoclonus
may have been present in some patients.
In this case, several observations argued
against epilepsy. Antiepileptic drugs were inef-
fective, limb jerks were stimulus sensitive, and
the child remained responsive during general-
ised jerks. Importantly, the EEG showed no
abnormalities during the generalised jerks,
which proved they were not epileptic.
Recognition of myoclonus has therapeutic
consequences because status epilepticus re-
quires aggressive treatment, with phenobarbi-
tal as the first choice. However, phenobarbital
is often ineVective for myoclonus1 3 and may
theoretically aggravate withdrawal signs due to
liver enzyme induction which facilitates clomi-
pramine clearance.4 Low dose clomipramine,
which allows for graduate tapering of clomi-
pramine concentrations, seems more eVective
for myoclonus.1 3
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Neonatal diabetes and severe
intracerebral haemorrhage
EDITOR,—A 20 day old baby boy was referred
to our hospital with a history of right sided
facial palsy, nystagmus, and seizures. He had
been born by normal vaginal delivery, at 36
weeks of gestation, with good Apgar score (8
and 9 at five minutes, respectively). He had
jaundice, for which he required phototherapy
for four days at the referring hospital, but was
otherwise normal.
Ten days after discharge he presented again
with a history of poor feeding and lethargy for
one day. On examination, he looked pale with
a full and tense anterior fontanelle. He was
febrile and tachypnoeic. A presumptive diag-
nosis of sepsis/meningitis was made and he
was given cefotaxime and ampicillin. Spinal
tap was deferred as the fontanelle was tense.
He developed intractable seizure, requiring
diazepam, phenobarbitone, and phenytoin.
In view of his deteriorating condition, he
was transferred to the university hospital. On
arrival, he was noted to be febrile and
lethargic. After stabilisation an emergency
computed tomography scan of the brain was
performed, which revealed cerebral oedema
and a large, left sided, intracerebral bleed, with
extension into the subarachnoid spaces and
ventricle. Investigations on admission revealed
severely deranged electrolytes. His serum glu-
cose was 51.2 mmol/l, sodium 170 mmol/l,
potassium 7.5 mmol/l, urea 39 mmo/l and
creatinine 246 µmol/l. The white cell count
was 17 × 109/l, with a haemoglobin of 156 g/l.
The platelet count was obtained from the
referring hospital because our specimen had a
small clot (125× 109/l). The coagulation
profile was normal (PT 15 seconds, APTT 45
seconds, D-Dimer > 0.5 < 1 µg/ml, fibrinogen
3.1g/l). The infant was treated symptomati-
cally with supportive care, but died on the
second day of admission.
The common causes for bleeding were
ruled out. There was no history of birth
asphyxia or trauma. The platelet counts and
coagulation profile were normal. Although the
chance of arterio-venous malformation as a
cause of spontaneous bleed cannot be ruled
out completely, the computed tomography
scan gave no indication of this. The diagnosis
of neonatal diabetes was supported by con-
comitant hyperglycaemia (51.2 mmol/l), gly-
cosuria, metabolic acidosis (pH 7.29, baseline
excess –16.3), dehydration and weight loss
(weight at admission was 2050 g compared
with birthweight of 2580 g).
Neonatal diabetes is rare. The incidence
rates reported from the UK and Germany are
1 in 400 000 and 1 in 500 000, respectively.1
As far as we are aware, no reports have been
published on the association between neonatal
diabetes and intracerebral haemorrhage.
However, previous reports have associated
hyperglycaemia with haemorrhagic transfor-
mation of the cerebral infarct.2 3 In a recent
study, Scott et al showed an increased
incidence of intracerebral haemorrhage with
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admission hyperglycaemia in adults.4 In an
animal model study, de Courten-Myers et al
reported 25-fold more extensive haemorrhage
in cats with hyperglycaemia compared with
normoglycaemic cats.2 Similarly, Broderick et
al associated hyperglycaemia with cerebral
bleed in two human adults.3 The exact mech-
anism by which hyperglycaemia induces cer-
ebral bleeding is not clear. It enhances lactic
acidosis in brain tissue and the combination of
hyperglycaemia and acidosis enhances en-
dothelial damage with subsequent extravasa-
tion of red blood cells through the leaky
vessels.3 There have been studies on the eVect
of glucose and acid base changes on brain
ischaemia.5 6
A causal link between hyperglycaemia and
intracerebral haemorrhage in neonates may be
diYcult to prove, but we look forward to other
prospective studies on the risks and mecha-
nisms of brain haemorrhage in neonates with
severe hyperglycaemia.
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Neonatal paracetamol poisoning
EDITOR,—Neonatal paracetamol poisoning is
rare. To date, there have been no definitive
therapeutic guidelines for its management. We
describe the successful use of N-acetylcysteine
in the management of a term infant who had
transplacentally acquired paracetamol poison-
ing.
A 2.88 kg term infant was born at home to
an 18 year old single mother. Five hours after
delivery the mother admitted to taking about
40 tablets (20 g) of paracetamol three hours
before delivery. Investigations performed on
both mother and baby nine hours after inges-
tion confirmed the presence of significantly
high serum concentratios of paracetamol
(table 1). The mother’s liver enzymes and
coagulation profile were both normal. The
infant, however, had evidence of hepatotoxic-
ity with a prolonged International Normalised
Prothrombin Ratio (INR) of 3, increased liver
enzymes, and hypoglycaemia (blood glucose 2
mmol/l) (table 1). At admission to our unit,
N-acetylcysteine was given according to the
following protocol:150 mg/kg in 5% dextrose
over 30 minutes, then 50 mg/kg in 5%
dextrose over 4 hours, then 100 mg/kg in 5%
dextrose/24 hours until the INR returned to
normal.
The infant was mildly jaundiced (day 1 of
life), alert, without enlarged liver and spleen or
evidence of a bleeding diathesis. Serial investi-
gations showed a gradual fall in the serum
paracetamol concentration. N-acetylcysteine
was continued until the INR returned to nor-
mal. Urine output was good and the infant
remained active. The synthetic function of
liver showed gradual improvement with nor-
malisation of INR at 48 hours. The infant was
discharged well on day 7 of life.
Even though no guidelines on safe limits for
paracetamol overdose in neonates have been
established, it would be safe to use those in use
for older children, while erring on the side of
caution. The beneficial eVects of
N-acetylcysteine for paracetamol overdose
have been documented in infants and
children,1–3 but there is no published evidence
of its use in the management of neonatal para-
cetamol overdose. Exchange transfusions have
been used,4 5 but increase the potential for a
rebound increase in blood concentrations,
necessitating repeat exchange transfusions,
because of tissue sequestration of paraceta-
mol.
N-acetylcysteine is a relatively safe drug, an
eVective antidote for paracetamol, and be-
cause of its antioxidant eVect, has also been
used in the management of non-paracetamol
fulminant liver failure.6 We suggest that
N-acetylcysteine should continue to be used
in neonatal paracetamol poisoning until the
INR returns to normal.
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“Dewatering” of the lungs
EDITOR,—The letter from Hills and Masters1in
response to my commentary of their paper2
raises some interesting points which require
further comment.
I stand corrected over my description of
their model of the alveolus as “dry.” This was
a short hand term on my part to distinguish
Hills’ theory on which he has published widely
from the more traditional theories of how pul-
monary surfactant works.
Their letter, however, does not challenge the
basic points I made in reluctantly refuting
their hypothesis. These were, firstly, that fetal
lung liquid can be absorbed before birth—that
is, before the establishment of an air–liquid
interface and thus before surface forces can
act—and secondly, that even in neonates who
have intact pulmonary surfactant function,
there is total failure of lung liquid removal
when sodium ion transport is abolished.3 The
latter finding, in particular, must make us
question whether surfactant has any role in
lung liquid removal at birth.
The authors make the novel suggestion in
their letter that the oligolamellar structures of
surfactant could be the barrier to diVusion at
intercellular junctions—an action which they
claim makes the lung epithelium relatively
tight and thus enhances its ability to secrete or
absorb liquid through generating osmotic
forces by ion movement. Before birth the pul-
monary epithelium is already “tight” and
restricts the passage of molecules the size of
sucrose and larger.4 The low permeability is
constant during gestation5 and does not
decrease (at least in the liquid filled lung)
when surfactant appears near term, a finding
which argues against this newly proposed
function for surfactant.
Measuring permeability in the air filled
postnatal lung is diYcult, but the evidence
suggests that there is a temporary increase in
permeability over the first 12 hours after birth
(probably as the result of stretch) which then
reverts to near fetal permeability levels.6 7 The
reason that it takes days to clear fluid from the
lungs in respiratory distress syndrome (RDS)
even after administration of exogenous sur-
factant, is because the epithelial barrier has
been breached in the early stages of the disease
and cannot maintain an osmotic gradient,
however hard the Na+ “pump” works. Indeed,
damage to the pulmonary epithelium in RDS
has been shown to occur within two minutes
of birth.8 It is the slow healing of the
epithelium, hindered by persistent baro-
trauma and high oxygen tensions, which
causes the prolonged recovery from severe
surfactant deficient RDS.
The picture included in the author’s letter
seems to provide evidence for the traditional
theory—that surfactant rests on a very thin
alveolar liquid layer and not vice versa. The
thickness of this layer measured in vivo by
physiological means in the air filled lung,
rather than by microscopy, is indeed very
small. The mean thickness being calculated at
only 0.1– 0.2 microns, indicating that in some
areas it will be even thinner.9 10
I accept that these physiological measure-
ments are no more able to settle the arguments
about how precisely surfactant is distributed
in the alveolus than can microscopy. However,
for ion transport and water movement to
work, there must be ready access to the
Table 1 Biochemical profile of mothers and infants
Neonates Mothers
Time from ingestion (h) 9 18 27 32 48 72 7 days 9 32
Paracetamol (mg/l) 133 67 25 <0.1 <0.1 147 <0.1
PT (sec) 44 14
INR 3 1.68 1.14 0.94 1.01
Bilirubin (mmol/l) 90 99 85 25 11
AST (U/l) 86 48 55 32 28
Creatinine (mmol/l) 89 81 89 61 53 50 52
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apically placed epithelial ion channels by ions
in the alveolar liquid—the alveolar liquid
would be better placed below any surfactant
forms rather than above them. A more
detailed discussion of the possible interactions
between surfactant and lung liquid movement
has been given elsewhere.11
The authors are to be complimented on
their thought provoking suggestions, but, ulti-
mately, all hypotheses must be supported by
experimental evidence.
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Detection of heart disease in infancy
EDITOR,—Gregory et al1 state that after neona-
tal examination, the 6–8 week examination
provides the only opportunity for detection of
heart disease in infancy, other than the oppor-
tunistic recognition of a murmur or the devel-
opment of symptoms. This is supported by the
most recent report of the joint working party
on Child Health surveillance,2 which states:
“there is no justification for carrying out a
screening check for heart murmurs after 8
weeks of age.”
In the Bath clinical area routine ausculta-
tion of the heart was, until recently, carried out
at the 8 month check, and indeed in the Wilt-
shire catchment area this is still current prac-
tice. A retrospective study was performed,
looking at the records of around 10 000
children seen over 27 months. Hospital
records, community child health records, and
General Practitioner records were reviewed, as
appropriate, to determine the outcome of
children referred to general paediatric outpa-
tient clinics with a murmur. Forty seven chil-
dren were seen and notes were available for
45.
When examined in outpatients, six children
(13.3%) had no audible murmur and 30 chil-
dren (66.7%) were felt to have an innocent
murmur. Nine children (20%) were thought
to have a cardiac lesion. These children were
all asymptomatic and all had had normal six
week checks. Of the nine children, two were
thought to have ventricular septal defects and
seven were referred to a paediatric cardiolo-
gist. Subsequently, three were found to have
structurally normal hearts, two pulmonary
valve stenosis, and one a ventricular septal
defect. There was no further information on
one child.
Therefore, as a result of the 8/12 check,
three children with ventricular septal defects
and two with pulmonary valve stenosis were
identified.
Our study highlights the importance of vigi-
lent opportunistic screening if the routine 8/12
check is dropped. Ways to promote opportun-
istic screening must be sought.
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BOOK REVIEW
Brain damage in the newborn and its
neurologic sequels. Towbin A. [Pp 764,
hardback $302]. PRM Publishing Ltd, 1998.
ISBN 0-9660551-0-1.
Clinicians working with children with cerebral
palsy see the end result of damage which
occurred many years before. To understand
the causes and timing of this damage, you
need to look at its origins in the fetal and new-
born periods, because it is now abundantly
clear that most cerebral palsy arises in pre-
natal life; in only a small proportion of
children is there evidence of injury at birth.
The causes are by no means understood.
Hypoxia and ischaemia have long been
regarded as the most important, but patho-
logical and epidemiological studies show that
very similar forms of damage also result from
maternal and placental infections, possibly
mediated by cytokines crossing the placenta
into the fetal brain, by metabolic disease,
iodine deficiency, etc.
The contribution of very early intrauterine
damage to birth asphyxia was first noted by
Sigmund Freud over 100 years ago; not all
birth asphyxia is what it seems. Many of these
infants were set up months beforehand for a
diYcult birth.
Dr Abraham Towbin recognised the value
of studying the fetal and neonatal brain. He
worked with the most eminent of neuro-
pathologists, Paul Yakovlev, and from him
learned the method of celloidin embedding.
Using this technique, these tiny, fragile, and
precious specimens can be embedded whole
in plastic and entire brain sections cut and
examined under the microscope, with unpar-
alleled preservation of the pathologic anatomy.
You won’t persuade a technician to undertake
this technique today; it is far too costly, both in
time and resources for modern laboratories.
This book represents a celebration of Dr
Towbin’s 40 plus years in paediatric neuro-
pathology. It is a meticulously documented
collection of over 200 case studies accompa-
nied by detailed obstetric and clinical histo-
ries. It is beautifully produced and the illustra-
tions are superb. They include gross and
microscopic pathology of the brain, placenta,
and body organs as well as many radiographs.
Most are full colour, every one is clean and
crisply focused, and the legends are economi-
cal.
The weakest part of the book is Dr Towbin’s
interpretation of the pathogenesis of develop-
mental brain damage. It is idiosyncratic and he
paints with a very broad brush. The clinical
chapters are scarcely more informative.
But the real value of this book is that it
allows us to share in a rare wealth of carefully
archived material; an invaluable resource for
pathologists, obstetricians, neonatologists,
neurologists and developmental psychiatrists.
This book has a timely message in an age of
ever-increasing litigation. Only a small pro-
portion of developmental brain damage oc-
curs at birth; in over 80% we still have to seek
causes and establish prevention in the prenatal
period.
M V SQUIER
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RadcliVe Infirmary, Oxford
CORRECTIONS
In last month’s edition (Arch Dis Child Fetal
Neonatal Ed) 1999;80, the following were
inadvertently published incorrectly:
In the Letters to the Editor section, several
names were omitted from Vascular ring: an
important cause of upper airways obstruc-
tion (F252–3). In addition to A Sharples, I N
Keengwe, I Ahmad, and O Dearlove should
have been included.
The figure legends in Serum malondialde-
hyde concentration in babies with hyper-
bilirubinaemia (Yigit, et al, F235–7) should
have been:
Figure 1 Correlation between malondialde-
hyde and bilirubin concentrations in group 1.
Figure 2 Correlation between malondialde-
hyde and bilirubin concentrations in group 2.
The first author of Body composition of
preterm infants during infancy (F188–
91) should have been R J Cooke and not
D J Rawlings, as published.
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